EE265 Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial
Abstract
Authors
Solomon Nuhoho Jyothi Menon Juliette Cattin Samuel J. Malkin Barnaby Hunt Barrie Chubb